$90MSeries A, 5 November 2026
Alethio Therapeutics raised $90 million in Series A funding.
- Amount
- $90M
- Stage
- Series A
- Announced
- 5 November 2026
- Leads
- Sofinnova Partners, RA Capital
- Other investors
- Oxford Science Enterprises, Cancer Research Horizons, University of Oxford
- Use of funds
- Advance lead program ATX-011 through Phase 1/2a studies toward Phase 3 readiness.
- Checked
- Amount and date checked against the press source
- Source
- Alethio Therapeutics Raises $90M in Series A Funding - FinSMEs FinSMEs